Akèy › Kansè tiwoyid › Texas › Houston
Etid klinik pou Kansè tiwoyid nan Houston, TX
12 etid pou Kansè tiwoyid ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- UT MD Anderson Cancer Center, Houston
Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
Ap rekriteEtid obsèvasyon
- MD Anderson Cancer Center, Houston
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Ap rekriteFaz 1/2
- MD Anderson Cancer Center, Houston
Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
Ap rekrite
- The University of Texas M. D. Anderson Cancer Center, Houston
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
Ap rekriteFaz 2
- MD Anderson Cancer Center, Houston
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Ap rekriteFaz 2
- MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Ap rekriteFaz 1/2
- MD Anderson Cancer Center, Houston
An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
Ap rekriteFaz 1Volontè an sante akeyi
- M D Anderson Cancer Center, Houston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Ap rekriteFaz 1/2
- MD Anderson Cancer Center, Houston
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Ap rekrite
- M D Anderson Cancer Center, Houston
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Ap rekriteFaz 2
- MD Anderson Cancer Center, Houston
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
Ap rekriteFaz 2
- MD Anderson Cancer Center, Houston
Etid Kansè tiwoyid nan lòt vil
- Washington, DC10 etid
- New York City, NY9 etid
- Boston, MA6 etid
- Philadelphia, PA6 etid
- Nashville, TN5 etid
- Durham, NC5 etid
- Los Angeles, CA5 etid
- San Francisco, CA4 etid
- San Antonio, TX4 etid
- Minneapolis, MN4 etid
- St. Louis, MO4 etid
- Memphis, TN4 etid
Lòt etid nan Houston
- Kansè Poumon ki pa ti selil145 etid
- Kansè nan tete126 etid
- Kansè (tout kalite)121 etid
- Kansè Metastatik104 etid
- Kansè kolorektal102 etid
- Kansè ovè89 etid
- Leksemi mieloïd egi85 etid
- Kansè poumon78 etid
- Kansè pwostat76 etid
- Kansè Endomèt68 etid
- Kansè pankreyas61 etid
- Melanom59 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.